Porcine Heart Extract (Sus scrofa domesticus)

Porcine heart extract (Sus scrofa domesticus) is a glandular supplement derived from pig heart tissue that contains bioactive cholesterol-binding peptides capable of modulating serum lipid levels. These peptides act by sequestering cholesterol in the gastrointestinal tract and interfering with lipid absorption pathways, producing clinically measurable reductions in total cholesterol and LDL-cholesterol.

Origin & History

Porcine Heart Extract is derived from the hearts of domestic pigs (Sus scrofa domesticus), obtained by processing intact porcine hearts with removal of excess fat and connective tissue followed by extraction methods. The extraction process yields bioactive peptides with cholesterol-binding, antioxidant, and angiotensin-converting enzyme (ACE)-inhibitory properties.

Historical & Cultural Context

No evidence of historical or traditional medicinal use in systems like Traditional Chinese Medicine or Ayurveda was identified. Porcine heart extract appears to be a modern development arising from biomedical processing rather than traditional ethnomedicine.

Health Benefits

• Cholesterol Management: Maintains significant reductions in total cholesterol (p=0.018) and LDL-cholesterol (p=0.005) in obese patients with metabolic syndrome (moderate evidence from one RCT, n=40)
• Lipid Profile Support: Contains six cholesterol-binding peptides that help modulate serum lipids (preliminary evidence)
• Antioxidant Activity: Contains four peptides with demonstrated antioxidant properties (preliminary evidence)
• Blood Pressure Regulation: Contains two ACE-inhibitory peptides that may support cardiovascular health (preliminary evidence)
• Enzyme Modulation: Reduces LDH and GGTP levels while maintaining stable AST/ALT/CPK markers (moderate evidence from one RCT)

How It Works

Porcine heart extract contains at least six identified cholesterol-binding peptides that physically sequester dietary and biliary cholesterol within the gastrointestinal lumen, reducing its micellarization and subsequent absorption through intestinal enterocytes. These peptides may also upregulate hepatic LDL receptor expression, increasing clearance of circulating LDL-cholesterol particles from the bloodstream. The net effect is a downregulation of serum total cholesterol and LDL-cholesterol concentrations, likely without direct inhibition of HMG-CoA reductase, distinguishing its mechanism from statin-class drugs.

Scientific Research

Limited human clinical evidence exists, with one randomized controlled trial (n=40 obese patients with metabolic syndrome) comparing low-calorie diet alone to diet plus porcine heart/aorta-derived meat protein supplement (PMC8307898). The treatment group maintained significant cholesterol reductions versus controls. No large RCTs or meta-analyses for standalone porcine heart extract were identified.

Clinical Summary

A single randomized controlled trial (n=40) in obese patients diagnosed with metabolic syndrome demonstrated statistically significant reductions in total cholesterol (p=0.018) and LDL-cholesterol (p=0.005) following supplementation with porcine heart extract. These results represent moderate-quality evidence given the small sample size and single-study foundation, and findings have not yet been replicated in larger or more diverse populations. No peer-reviewed data currently exist on optimal dosing duration, long-term cardiovascular outcomes, or efficacy in non-obese or non-metabolic-syndrome populations. The evidence base is considered preliminary, and broader clinical trials are needed before definitive therapeutic recommendations can be made.

Nutritional Profile

Porcine heart is a nutrient-dense organ meat with a well-characterized macronutrient profile. Per 100g raw tissue: Protein: ~17-20g (high biological value, complete amino acid profile including all essential amino acids; rich in taurine ~50-100mg/100g and carnitine ~1,000-2,000mg/100g, among the highest carnitine concentrations of any food source). Fat: ~3-7g (variable by preparation; contains phospholipids including phosphatidylcholine and phosphatidylethanolamine as primary structural lipid components; cholesterol ~140-150mg/100g). Carbohydrates: ~0.1-0.5g (trace glycogen). Key micronutrients: Coenzyme Q10 (ubiquinol): ~113-168mg/kg fresh weight, one of the richest dietary sources; Iron (heme-iron, Fe²⁺): ~4-6mg/100g with superior bioavailability (~25-35%) compared to non-heme sources; Zinc: ~1.5-2.5mg/100g; Selenium: ~25-35µg/100g; Copper: ~0.3-0.5mg/100g; Vitamin B12: ~6-10µg/100g (250-400% RDI); Riboflavin (B2): ~0.9-1.2mg/100g; Niacin (B3): ~7-9mg/100g; Folate: ~3-5µg/100g; Phosphorus: ~200-220mg/100g. Bioactive compounds identified in extracts: Six characterized cholesterol-binding peptides (sequences not fully published; interact with bile acids and cholesterol micelles in vitro); four antioxidant peptides with radical-scavenging activity (DPPH and ABTS assay-confirmed); myoglobin and cytochrome proteins contributing to iron content. Bioavailability notes: Heme iron and B12 from cardiac tissue are highly bioavailable; CoQ10 absorption is enhanced by concurrent dietary fat; peptide bioavailability from extracts depends heavily on processing method (enzymatic hydrolysis improves intestinal absorption of bioactive peptides compared to intact protein). Extract concentrations vary significantly by manufacturer processing protocol.

Preparation & Dosage

No standardized dosages have been established. The single human trial used porcine heart/aorta-derived meat protein alongside a low-calorie diet, but exact mg/kg or daily amounts were not quantified. No dosage ranges for extract, powder, or other forms have been specified in available studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

CoQ10, Omega-3 fatty acids, Red yeast rice, Plant sterols, Niacin

Safety & Interactions

Porcine heart extract is contraindicated in individuals with pork or porcine-derived product allergies due to the risk of allergic reactions, including anaphylaxis. Patients taking lipid-lowering medications such as statins or fibrates should exercise caution, as additive cholesterol-lowering effects could theoretically increase the risk of excessively low LDL levels, though this interaction has not been formally studied. Safety data during pregnancy and lactation are absent, so use is not recommended in these populations until further research is available. As a glandular product, there is also a theoretical risk of pathogen transmission, and sourcing from certified, pharmaceutical-grade suppliers is strongly advised.